Breast Cancer Coverage From Every Angle

Recent News

SABCS 2018: Comparing Letrozole With and Without Palbociclib in Metastatic Breast Cancer
Risk Class May Be Linked to Response to Breast Cancer Treatments
SABCS 2018: Novel Tool for Assessing Risk of Chemotherapy Toxicity in Older Patients With Breast Cancer
Rethinking Screening Mammography in Women Aged 75 and Older
SABCS 2018: Duration of Adjuvant Trastuzumab in Early Breast Cancer
SABCS 2018: When to Initiate Adjuvant Chemotherapy in Triple-Negative Breast Cancer
Shorter Course of Trastuzumab in Some HER2-Positive Early Breast Cancers
Machine-Learning Prognostic Risk Model for African American Women With Breast Cancer
Endocrine Therapy on Trial in Male Breast Cancer
HDAC Inhibitor Studied in Treatment of Advanced Breast Cancer
City of Hope Launches CAR T-Cell Trial in Patients With Breast Cancer and Brain Metastases
ESMO 2018: Zoledronic Acid and Letrozole vs. Tamoxifen in Early Breast Cancer
FDA Grants Priority Review to Atezolizumab Plus Chemotherapy in Triple-Negative Breast Cancer
ESMO 2018: Targeting the Tumor Genome in Advanced Breast Cancer
ASTRO 2018: Radiation After Surgery for Low-Risk Ductal Carcinoma in Situ
ESMO 2018: Novel Combination Therapy for Advanced Breast Cancer
Novel Regional Anesthesia Technique for Pain Management After Mastectomy
ASTRO 2018: Long-Term Effects of Once-Weekly vs. Conventional Breast Radiation
Active Monitoring for Low-Risk Ductal Carcinoma in Situ
ESMO 2018: Atezolizumab Plus Nab-Paclitaxel in Metastatic Triple-Negative Breast Cancer
MIBC 2018: Evaluating Validity of Online Breast Cancer Risk Assessment Tool
MIBC 2018: Musculoskeletal Side Effects of Breast Reconstructive Surgery
ESMO 2018: Are Women With Early Breast Cancer Adhering to Hormonal Therapy?
Quality Care Symposium: Assessing Delivery of Care for Women With Metastatic Breast Cancer
FDA Approves Talazoparib for Germline BRCA-Mutated HER2-Negative Breast Cancer
Does Adjuvant Bevacizumab Improve Outcomes in HER2-Negative Patients?
Quality Care Symposium: Prevalence of Unnecessary Scans for Early-Stage Breast Cancer
International Cancer Immunotherapy Conference: Early Study Results of Vaccine in HER2-Positive Cancers
Quality Care Symposium: Few Women Discuss Financial Aspect of Cancer Care With Physicians
Are Patients Treated for Breast Cancer at Increased Risk of CML?
Polymorphism and Radiation-Induced Fibrosis in Patients With Early-Stage Breast Cancer
How Does Talazoparib Compare With Chemotherapy for Breast Cancer Subgroup?
Novel Combination Therapy for ERBB2/HER2-Positive Metastatic Breast Cancer
Chemotherapy-Related Cardiotoxicity in Women With Breast Cancer
Where Do Surgeons Stand on Axillary Dissection in Early Breast Cancer?
Triple-Negative Breast Cancer: Genes Linked to Increased Risk Identified
Sensitivity of Digital Mammography Plus Tomosynthesis in Breast Cancer Screening
Is Body Mass Index Associated With Premenopausal Breast Cancer?
Autologous Versus Implant Breast Reconstruction: Postoperative Risks and Quality of Life
Artificial Intelligence Software Solution Granted Clearance by FDA
Does Fertility Treatment Increase Risk of Breast Cancer?
Receipt of Genetic Testing After Breast Cancer Diagnosis May Be Affected by Surgeon
Breast Cancer Prevalence: Flight Cabin Crew Versus General Population
European Commission Approves Biosimilar of Trastuzumab for HER2-Positive Breast Cancer
FDA Grants Priority Review for Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
FDA Approves Device for Guiding SLN Biopsies in Breast Cancer
FDA Expands Indication for Ribociclib in Advanced Breast Cancer
Combined Niraparib and Pembrolizumab for Advanced Triple-Negative Breast Cancer
SNMMI 2018: Can PET/CT Substitute for IHC Assessment of Estrogen Receptor Status in Recurrent Breast Cancer?
‘RESPECT’ Given to Adjuvant Trastuzumab Monotherapy in Elderly Women With Breast Cancer
Neoadjuvant Talazoparib in BRCA-Positive Breast Cancer
Novel Combination Therapy Studied in Endometrial, Ovarian, and Breast Cancers
FDA Accepts Supplementary Premarket Approval Application for BRACAnalysis CDx for Metastatic Breast Cancer
ASCO 2018: Does Adjuvant Denosumab Improve Outcomes in Postmenopausal Women With Breast Cancer?
New Study Data Show Reduction in Breast Cancer Recurrence With Multimodality Lumpectomy
ASCO 2018: Weighing Benefits/Risks of Exemestane Therapy in Premenopausal Women With Breast Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.